ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...
Women's health only receives 6% of private health care investment, or less than one in ten dollars, despite women representing almost half of the global population. Of these limited funds, 90% flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback